Kyntra Bio Inc

Insightful look at Kyntra Bio’s CEO insider sales & options: what the 2,800‑share trade signals for investors and the company’s future.

Insider sales at Kyntra Bio reveal tax‑related moves, not a sharp decline. Watch Phase 1b/2 FG‑3246 data before betting on the stock’s future.